Pancreatic-derived factor (PANDER) is a cytokine-like peptide highly expressed in pancreatic β-cells. PANDER was reported to promote apoptosis of pancreatic β-cells and secrete in response to glucose. Here we explored the effects of glucose on PANDER expression and the underlying mechanisms in murine pancreatic β-cell line MIN6 and primary islets. Our results showed that glucose upregulated PANDER mRNA and protein levels in time-and dose-dependent manner in MIN6 cells and pancreatic islets. In cells expressing CREB dominant-negative construct, glucose failed to induce PANDER gene expression and promoter activation.
Introduction PANDER (pancreatic-derived factor), also named FAM3B, is a novel cytokine-like peptide that was recently identified during a search for novel four-helix-bundle cytokines using structure-based methods (1) . The PANDER gene is strongly expressed in pancreatic islets and slightly expressed in the prostate and small intestine. Both human and mouse PANDER contain 235 amino acids, with 78% homology and 4 conserved cysteines (1) . PANDER protein is present in both α-and β-cells of pancreatic islets, it appears to colocalize with both glucagon and insulin (2) . Recombinant PANDER protein induces apoptosis of α-and β-cells of mouse, rat, and human islets in a dose-as well as time-dependent manner (2, 3) . Treatment with IFN-γ or a combination of IL-1β, TNF-α, and IFN-γ up-regulates PANDER gene expression in mouse islets and in insulin secreting β-cell line in a time-and dose-dependent manner (4) , suggesting that PANDER may function as a downstream signal in cytokine-mediated β-cell dysfunction and death. Recently, glucose was reported to induce PANDER secretion in rodent β-cell line and islets (5) . In this study we show that glucose can induce PANDER expression in mouse pancreatic islets and β-cell line at both mRNA and protein levels and demonstrate that the effect of glucose on PANDER gene expression is mediated by multiple signaling pathways.
Materials and Methods

Pancreatic islet preparation and cell culture
All experiments using animal were in accordance with the National Institutes of Heath Guide for the Care and Use of Laboratory Animals and were approved by the Biological Research Ethics Committee, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. Pancreatic islets were isolated from C57/BL6 mice (from Shanghai SLAC Laboratory Animal Company) by type V collagenase (Sigma, Louis, MO) digestion followed by Ficoll 400 (Amersham Pharmacia Biotech, Piscataway, NJ) gradient separation, as described previously (6) . Islets were maintained in DMEM (Gibco BRL, Burlington, Ontario, Canada) medium containing 5.6 mM glucose, 10% FBS, 100 units/ml penicillin, 100 μg/ml streptomycin. 100 islets were pooled as one sample for further experiments. Murine pancreatic β-cell line MIN6 cells were cultured in DMEM containing 5.6 mM glucose, 10% FBS, 100 units/ml penicillin and 100 μg/ml streptomycin in a humidified atmosphere at 37°C with 5% CO 2 .
RNA extraction and real-time PCR
Total RNA was extracted from MIN6 cells or mouse pancreatic islets using the Trizol reagent (Invitrogen, Carlsbad, CA) and depleted of contaminating DNA with RNase-free DNase according to manufacturers' instructions. cDNA was synthesized from 2 μg RNA with M-MuLV reverse transcriptase and random hexamer according to manufacturer's instructions (Fermentas, Burlington, Ontario, Canada). Quantitative real-time PCR was performed by using an ABI Prism 7500 sequence detector (Applied Biosystems Inc, Foster City, CA). Briefly, reverse-transcribed cDNA in triplicate samples were checked for PANDER mRNA level with SYBR Green PCR master kit (TOYOBO Biotech, Osaka, Japan) according to manufacturer's instructions. Primers for murine PANDER were: 5'-GCGAC AAGTA TGCCA AGA (sense); 5'-GACGA CAGCA ATGTTT ATCC (antisense). Mouse β-actin primers were: 5'-CAACG AGCGG TTCCG AT (sense); 5'-GCCAC AGGAT TCCAT ACCCA (antisense) (7) . The assays were initiated with 5 min at 95°C, and then 40 cycles of 15 s at 94°C, 1 min at 60°C. A threshold cycle, C T (cycle of gene amplification that exceeds the minimum level of fluorescent detection), was calculated for both PANDER and β-actin. Amplification of the PANDER cDNA was normalized to β-actin expression. Relative levels of PANDER mRNA expression were calculated using the 2 -ΔΔC T method (8) .
Cell viability assay
The effect of different inhibitors on the viability of MIN6 cells was determined using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) method. Briefly, cells (1×10 3 /well) were plated in 96-well plate, incubated at 37°C for 24 h, and treated with the indicated concentrations of the compounds for 3 h. MTT reagent (Sigma) (0.2 μg/μl per well) was added and incubated at 37°C for 4 h. The intracellular purple formazan product was dissolved with HCl/isopropanol (0.04 mM). The absorbance at 570 nm (reference at 630 nm) was determined by a microplate reader Multiskan JX (Themo LabSystems). Each experiment was repeated three times in triplicate samples.
Western Blotting assay
After a 2-h stabilization period at 37 °C in buffer containing 124 mM NaCl; 5.6 mM KCl; 2.5 mM MgCl 2 ; 2.5 mM CaCl 2 ; 20 mM HEPES, and 1 mM glucose (pH 7.0) (9), either in the absence or the presence of inhibitors, MIN6 cells or mouse pancreatic islets were stimulated with glucose as indicated in figure legends. The cells were then lysed with cold RIPA lysis buffer containing 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 0.1% SDS, 100 mM Tris (pH 8.0), 10 mM NaF, 1% deoxycholic acid, 1 mM PMSF, 1 mM sodium vanadate, 1 mM DTT, 10 μM Aprotinin and 4 μM leupeptin. The cell lysates were centrifuged at 14,000 rpm for 20 min to remove insoluble materials, and the concentration of protein was determined by Bradford assay. Western blotting of PANDER or phosphorylated ERK1/2 and CREB were performed according to the manufacturers' instruction. Briefly, protein were electrophoresed on 10% SDS-PAGE gel, and transferred onto polyvinylidene difluoride membranes (Millipore Corporation, Bedford, MA). The membranes were blocked with 5% nonfat milk, and then were incubated with primary antibodies overnight at 4°C. After incubation with an HRP-conjugated secondary antibody, the protein bands were detected with a Supersignal West Pico chemiluminescenct substrate (Pierce, Rockford, IL) and X-Omat BT film (Eastman Kodak Company, Rochester, New York). For detection of total ERK and CREB, the membranes were stripped with Restore Western Blot Stripping Buffer (Pierce), followed by incubation with specific antibodies. Monoclonal antibody against p-ERK1/2 was bought from Santa Cruz Biotechnology (Santa Cruz, CA). Antibodies against ERK1/2, p-CREB and CREB were obtained from Cell Signaling Technology (New England Biolabs, Beverly, MA). Antibody against mouse PANDER protein was purchased from R&D Systems (R&D Systems, Inc., MN). To determine whether glucose-induced increase of PANDER mRNA levels was due to the increase of PANDER mRNA stability, MIN6 cells pretreated with 5.6 mM or 16 mM glucose for 2 h were cultured with 5 μg/ml actinomycin D for 2, 4, 6 h before PANDER mRNA levels were examined by real-time PCR. As shown in Fig.1D , the half-life of PANDER mRNA in MIN6 cells in control medium with 5.6 mM glucose was 5 h. In the presence of 16 mM glucose, although the levels of PANDER mRNA were markedly increased, there was no significant difference in the curves of mRNA decay, suggesting that glucose mainly increases the PANDER transcription in MIN6 cells. -PKC-CREB pathways are involved in glucose-induced PANDER gene expression It was reported that glucose-induced calcium influx activated the transcription factor CREB, which is required for glucose homeostasis and islet-cell survival by regulating β-cell gene expression (11) . Glucose has bee shown to induce ERK1/2 phosphorylation through activation of PKA in pancreatic β-cells, and calcium influx is required for glucose-induced ERK1/2 phosphorylation (12). Thus we checked if glucose induced PANDER gene expression through activation of Ca 2+ -PKA-ERK1/2-CREB pathway. Pretreatment of MIN6 cells with EGTA and BAPTA/AM, extracellular and intracellular calcium chelator, respectively, completely abolished glucose-induced PANDER gene expression (Fig. 4A) . Nifedipine, a voltage-dependent Ca 2+ channel inhibitor, partly but dose-dependently inhibited glucose-induced PANDER gene expression (Fig. 4A) . EGTA, BAPTA/AM and Nifedipine at tested concentrations had no effect on cell viability (Fig. 4B) (Fig. 4C and D) . H89 and PD98059 at tested concentrations did not affect cell viability (Fig. 4F) . These results indicate the involvement of PKA and ERK1/2 activation in regulation of PANDER gene expression by glucose. We observed that H89 at low and high concentration both inhibited glucose-induced PANDER mRNA expression Fig. 4C . As H89 at high concentration also inhibits PKC (13), we then examined whether PKC was involved in glucose-induced PANDER gene expression. Go6976, an inhibitor of Ca 2+ -dependent PKCα and PKC β1 , significantly inhibited 16 mM glucose-induced PANDER mRNA expression ( Fig. 4E ) and had no effect on cell viability (Fig. 4F) , suggesting that Ca 2+ -dependent PKCα and PKC β1 were also involved in glucose-stimulated PANDER gene expression.
Construction of the PANDER
We next tested if glucose could induce CREB phosphorylation through the activation of Ca 2+ -PKA-ERK1/2 and Ca 2+ -PKC pathways.
When mouse pancreatic islets were treated with 16 mM glucose for different times, ERK1/2 and CREB were transiently phosphorylated (Fig.  5A ). The phosphorylation of ERK1/2 happened earlier than that of CREB. The maximal phosphorylation of ERK1/2 and CREB reached at 5 minutes after glucose stimulation (Fig. 5A) . Pretreatment of MIN6 cells with EGTA, nifedipine, H89, or PD98059 significantly inhibited glucose-induced ERK1/2 phosphorylation (Fig. 5B) . H89, PD98059, or Go6976 treatment completely inhibited glucose-induced CREB phosphorylation (Fig. 5C) 
Glucose induces PANDER gene expression through phosphatidylinositol 3-kinase (PI3K)-and reactive oxygen species (ROS)-related pathways
PI3Ks are proteins coupled to a variety of cell surface receptors and play a key role in signal transduction cascade regulating fundamental cellular functions such as transcription, proliferation and survival. Glucose has been shown to regulate preproinsulin gene expression through activation of PI3K (15) and stimulate insulin secretion through activation of nuclear factor-κB (NF-κB) (16) in MIN6 cells. PANDER is reported to be localized to insulin-containing granules in β-cells and secret in response to glucose (4, 5) , and our results showed that PANDER gene expression was up-regulated by glucose. These results suggest that the mechanisms involved in PANDER gene expression by glucose may be similar to that of insulin. To examine if PI3K and NF-κB were involved in glucose-induced PANDER expression, cells were treated with different concentrations of wortmannin (PI3K inhibitor), or PDTC (NF-κB inhibitor) before glucose stimulation, then PANDER gene expression was checked by real-time PCR. Preincubation of cells with wortmannin ( Fig.7A and B) , or PDTC ( Fig.  7C and D) , significantly inhibited 16 mM glucose-enhanced PANDER gene expression in MIN6 cells and mouse pancreatic islets. PDTC and wortmannin at tested concentrations did not affect cell viability (Fig.  7F) . When we analyzed the promoter region of PANDER gene with AliBaba2 program (17) , no NK-κB binding site was found. As PDTC is also a nonspecific antioxidant (18, 19) , we tested if ROS was involved in glucose-induced PANDER gene-expression. As shown in Fig. 7E , N-acetylcysteine (NAC), an antioxidant (20) , significantly inhibited glucose-induced PANDER gene expression. NAC at tested concentration had no effect on cell viability (Fig. 7F) . These results suggest that activation of PI3K and production of ROS are necessary for the up-regulation of PANDER gene expression by glucose, and the inhibitory effect of PDTC on glucose-induced PANDER gene expression may be mediated by its antioxidant activity. We further examined the effect of wortmannin, PDTC and NAC on glucose-induced PANDER promoter activation in MIN6 cells. PDTC, wortmannin, or NAC significantly inhibited glucose-induced luciferase expression in cells transfected with PANDER promoter construct -338/+491 or +1/+491, respectively (Fig. 8) , with more potent efficiency in cells expressing -338/+491 construct. These results confirmed that glucose regulated PANDER gene expression in MIN6 cells via PI3K-and ROS-related pathways, and suggest that PI3K-and ROS-related transcription modulators are present widely in the promoter region of PANDER gene.
Discussion
In this project we studied the effect of glucose on PANDER gene expression in both pancreatic β-cell line MIN6 and isolated mouse pancreatic islets. Our data show that glucose induces PANDER expression at mRNA and protein level but has no effect on PANDER mRNA stability. We demonstrate that glucose induces PANDER gene expression in pancreatic β-cells through multiple pathways.
PANDER is a novel gene that was recently discovered during a search for novel four-helix-bundle cytokines using structure-based methods (1) . Northern blot analysis showed the greater expression of PANDER in human pancreas and to a lesser extent in small intestine and prostate. Immunohistochemistry confirmed the presence of PANDER reactivity in the islets of Langerhans. A study with confocal microscopy and immunogold electron microscopy showed that PANDER was localized to the insulin-containing secretory granules in both murine β-cell line β-TC3 and rodent islet β-cells (4), suggesting that the regulation of PANDER expression and release may be similar to that of insulin.
Insulin biosynthesis and secretion from β-cells of islets of Langerhans are triggered by increased concentrations of circulating glucose, so we examined if PANDER gene expression was also regulated by glucose. We found that glucose induced PANDER gene expression in both MIN6 cells and murine primary islets, and the maximum effect of glucose reached at 2 h. We analyzed the sequence of the promoter region of PANDER gene with AliBaba2 program (17) and found that there is a binding site for transcription factor CREB at +21/+30. When MIN6 cells and murine pancreatic islets were transfected with dominant-negative CREB expression vector A-CREB, glucose failed to induce PANDER gene expression ( Fig. 2B and C) . MIN6 cells expressing a luciferase reporter construct +1/+491 containing the CREB binding site in the promoter region of PANDER responded to glucose in a dose-dependent manner (Fig.  6B) . Introduction of A-CREB attenuated glucose-induced luciferase expression (Fig.  6C ). These results demonstrate that CREB is involved in glucose-induced PANDER gene expression. In support of our results, Dr. Wolf's group reported that murine β-TC3 cells and primary islets transfected with luciferase reporter plasmids constructed with the murine PANDER promoter region showed a strong response to glucose, with a robust increase in luciferase expression in a dose-depend manner for +1/+491 constructs (14) .
Previous studies showed that glucose-induced calcium influx activated the transcription factor CREB, which was required for glucose homeostasis and islet-cell survival by regulating β-cell gene expression, such as the insulin gene and the anti-apoptotic gene bcl2 (11) . Pancreatic β-cell ERK1/2 activation is required for the regulation of insulin gene expression by glucose (21, 22 (30, 32, (37) (38) (39) . The binding sites of the above mentioned transcription factors are all existed in the promoter region -338/+491 of PANDER gene (Table 2) . Therefore, the activation of these transcription factors by their respective upstream molecules, such as PKA, PKC, ERK1/2, and PI3K, may also be involved in glucose-induced PANDER gene expression but need further investigation.
Although PDTC, the NF-κB inhibitor significantly inhibited glucose-induced PANDER promoter activation and PANDER mRNA expression ( Fig. 8 and Fig. 7 C, D) by MIN6 cells and primary pancreatic islets, we did not found NF-κB binding sites in the promoter region of PANDER gene. As glucose induces the production of ROS by pancreatic β cells (40) and PDTC has been shown to be a potent antioxidant both in vitro and in vivo (18, 19) . We tested if ROS was involved in glucose-induced PANDER gene expression. Our results showed that NAC, which bolsters endogenous glutathione (a key free radical scavenger) synthesis and displays antioxidant, as well as free radical scavenging actions (20) , significantly inhibited glucose-induced PANDER gene expression and promoter activation. Therefore, the inhibitory effect of PDTC on glucose-induced PANDER gene may be mediated by its antioxidant activity. ROS has been reported to mediate high glucose-induced activation of PKC, ERK, Egr-1, AP-1, and Sp-1 (41) (42) (43) (44) . Thus, these ROS signaling molecules and transcription factors existed in the promoter region of PANDER gene may also be involved in glucose-induced PANDER gene expression.
Although the physiological role of PANDER is unknown, recombinant PANDER protein induces apoptosis of α-and β-cells of mouse, rat, and human islets in a dose-as well as time-dependent manner (2), it is conceivable that PANDER may play role in β-cell death in the context of diabetes. PANDER gene expression is up-regulated by INFγ, a cytokine implicated in the pathogenesis of type 1 diabetes (4), suggesting PANDER may contribute to the pathogenesis of β-cell death. Recent studies showed that glucose stimulated PANDER secretion dose-dependently in β-cell lines and primary islets but not in α-cells, and PANDER is likely co-secreted with insulin via the same regulatory mechanisms (5). Our present study showed that glucose induced PANDER gene expression in pancreatic β-cells through the Ca 2+ -PKA-ERK1/2-CREB, Ca 2+ -PKC-CREB and PI3K-, ROS-related signaling pathways. An understanding of how PANDER is regulated along with the pivotal molecules involved is helpful to further elucidate the potential function of this novel cytokine. As PANDER is expressed by pancreatic β-cells and response to glucose in a similar way to those of insulin, and is a pro-apoptotic factor, PANDER may be involved in glucose homeostasis and β-cell homeostasis. The effect of PANDER on glucose homeostasis is under investigation. The -338/+491 (A) or +1/+491 (B) PANDER promoter luciferase construct was co-transfected with the pRL-TK renilla luciferase reporter plasmid into MIN6 cells in medium containing 5 mM glucose. After 42 h, medium containing 2 or 16 mM glucose were added and luciferase activity was measured 5 h later. 1 μM PDTC, 100 nM wortmannin (Wor), or 1 mM NAC were added 2 h before harvesting the cells for luciferase assay. Luciferase activity was normalized to renilla expression of the pRL-TK plasmid and is shown as fold over the activity of the construct at 2 mM glucose. **: P<0.01, normalized luciferase activity at 16 mM glucose versus 2 mM glucose. † : P <0.05, † † : P < 0.01 vs. cells stimulated with 16 mM glucose alone. All data are shown as mean± SEM from three independent experiments with each condition tested in triplicate. Table 1 . Primers for creation of PANDER promoter luciferase constructs Name Sequence -2338 forward, 5′-GCGGTACCAGGAGGGCTAGAGTTCATGATGGCA-3´ -1338 forward, 5′-GCGGTACCTCTCTGAGGGCTCCCACACACATAT -3´ -338 forward, 5′-GCGGTACCCTTTGGGCTCCTTGGAAGAGGAGGAA -3´ +1
forward, 5′ -GCGGTACCACATGTCAGCAAGGGGGCAGTGT -3´ +491 reverse, 5′-GCACGCGTGCTCTTGGCTGCAATCCCCA -3´ The name of the primer indicates the position of the primer relative to the transcriptional start site located 520 bp upstream of PANDER translational start codon. The restriction sites of Kpn I (GGTACC) and Mlu I (ACGCGT) are underlined. 
